Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Ubiquitin specific peptidase 17 like family member 28 (USP17L28) encodes a deubiquitinating enzyme that removes conjugated ubiquitin from substrate proteins, regulating their stability and turnover. It is a protein-coding gene belonging to the USP17 family and contributes to important cellular mechanisms, including cell cycle progression, apoptosis, cell migration, and response to viral infection. USP17L28 is localized in the nucleolus and exhibits cysteine-type deubiquitinase activity along with RNA and hyaluronic acid binding[1][8][9]. Its functional paralog, USP17L27, shares related activities. While USP17L28 has not yet been directly linked to specific drug interactions or validated as a clinical biomarker or therapeutic target, its family members have associations with cancer and cell death regulation.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Ubiquitin specific peptidase 17 like family member 28 (USP17L28).